Delivery Order SPE2DR25D1103-SPE2DR26FE249
- Not listed
- The Defense Logistics Agency awarded a $1,401.99 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price, competitively awarded contract utilizes no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,655.19 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop medication in 3ML units. This firm fixed-price delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,401.99 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution in a 3 mL formulation. This firm fixed-price delivery order, issued on November 28, 2025, represents a non-competitive, non-set-aside procurement under the company's existing DLA contract vehicle. The order is scheduled for completion by December 1, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $7,011.60 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3 mL units) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $13,997.08 to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on August 26, 2025, with a completion date of August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Miebo 100% eye drop medication in 3 mL units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,325.38 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,030.93 of Miebo 100% eye drops (3mL) on December 8, 2025, with completion scheduled for December 9, 2025. This non-competitive delivery order represents a firm fixed price transaction executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $26,971.47 to AmerisourceBergen Drug Corp for Miebo 100% eye drop product (3ml units) on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $6,217.21 to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions to AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE249Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,654.93 to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3mL) on December 9, 2025, with a completion date of December 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical transaction within the broader federal medical supply chain. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal healthcare procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical products to support military and veteran healthcare systems globally. The parent IDC serves as a flexible vehicle enabling the company to fulfill diverse pharmaceutical needs, including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 12/8/25 |